Vetoquinol SA

EPA:VETO.PA

72.6 (EUR) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

20242023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 539.196529.271539.779521.272427.467395.99367.941352.173350.354342.612315.298299.727298.293284.137282.041257.057234.395233.364211.591196.617
Cost of Revenue 151.747237.891367.411353.899303.491190.102171.909165.455170.285168.995154.841149.957112.19163.856158.86286.16676.249129.85372.9168.756
Gross Profit 387.449291.38172.368167.373123.976205.888196.032186.718180.069173.617160.457149.77186.103120.281123.179170.891158.146103.511138.681127.861
Gross Profit Ratio 0.7190.5510.3190.3210.290.520.5330.530.5140.5070.5090.50.6240.4230.4370.6650.6750.4440.6550.65
Reseach & Development Expenses 2.36540.1253128.429.98226.4125.524.222.121.9201.7151.961000000
General & Administrative Expenses 77.985159.4471.95166.62554.06155.05549.6743.81246.19640.96538.25136.18735.7664.1833.85700018.05915.073
Selling & Marketing Expenses 24.21723.11523.56926.85315.35214.2113.3812.75612.22912.14211.99911.1149.8089.23500009.6769.191
SG&A 102.202182.55560.15753.96736.169138.765134.995130.284124.22121.93112.776105.32845.5744.1833.85700027.73524.264
Other Expenses 205.56-5.539-7.897-5.134-6.917-5.477-4.647-4.361-5.218000107.409-3.17391.028130.898120.27175.43386.58281.726
Operating Expenses 310.127217.11693.05490.10171.486165.075147.884143.56140.997137.819123.744118.216154.69888.44391.028130.898120.27175.433114.317105.99
Operating Income 77.32274.26479.31477.27252.4945.9848.27445.64342.07238.74635.15433.53931.44631.8232.15128.92527.58728.07824.85118.835
Operating Income Ratio 0.1430.140.1470.1480.1230.1160.1310.130.120.1130.1110.1120.1050.1120.1140.1130.1180.120.1170.096
Total Other Income Expenses Net 3.692.641-1.260.368-4.76-0.1750.176-2.451-0.336-2.293.212-0.941-0.8540.23-1.825-3.971-3.135-4.504-4.824-2.326
Income Before Tax 81.01276.90568.64782.94832.33540.71148.39743.20339.66636.45637.65632.22130.59232.0530.32624.95424.45223.57420.02716.509
Income Before Tax Ratio 0.150.1450.1270.1590.0760.1030.1320.1230.1130.1060.1190.1080.1030.1130.1080.0970.1040.1010.0950.084
Income Tax Expense 22.33221.3420.64920.20913.39112.46412.1718.36511.83512.29611.8848.6368.0199.3498.0656.7415.8824.9254.1964.063
Net Income 58.68555.5647.99562.86119.22128.58936.25934.83127.82724.15625.76623.5822.56922.69522.25518.20718.56418.64215.82412.441
Net Income Ratio 0.1090.1050.0890.1210.0450.0720.0990.0990.0790.0710.0820.0790.0760.080.0790.0710.0790.080.0750.063
EPS 4.984.74.065.311.632.423.062.942.352.042.171.991.911.941.981.621.641.651.59130
EPS Diluted 4.984.74.065.311.632.423.062.942.352.042.171.991.911.941.981.621.641.651.57127
EBITDA 114.077112.326103.458116.85659.29258.79460.01957.0955.52151.30851.10244.40843.61545.28243.33336.47837.79738.54833.25526.676
EBITDA Ratio 0.2120.2120.1920.2240.1390.1480.1630.1620.1580.150.1620.1480.1460.1590.1540.1420.1610.1650.1570.136